Northeast Georgia Medical Center Braselton recently achieved a breakthrough in men’s healthcare by performing an innovative treatment for enlarged prostates.
The Northeast Medical Center and Georgia Urology made a “significant breakthrough” last month when they performed the first Aquablation procedure at NGMC Braselton. The new medical procedure will expand the center's treatment offerings for men by providing care for a condition that is said to affect millions worldwide.
The procedure was the result of a collaboration spearheaded by Dr. Brent Sharpe and Dr. Robert Fisher from Georgia Urology, along with Dr. David Stanley from NGMC.
Enlarged prostates, otherwise known as Benign Prostatic Hyperplasia (BPH), is a condition where the prostate gland enlarges, leading to problematic urinary symptoms such as frequent urination, weak urine flow or incomplete bladder emptying, according to NGMC officials.
The outcome of BPH is said to have a significant impact on a man’s quality of life by interrupting sleep patterns and daily activities.
Aquablation therapy is a minimally invasive surgical procedure that uses water jet technology to remove excess tissue from an enlarged prostate without the need for any incisions. This reduces bleeding and allows for a faster recovery as compared to traditional surgical procedures.
Georgia Urology has reportedly performed over 1,000 Aquablation therapy procedures, which is said to be more than any other urology practice in the United States.
NGMC’s investment in the AquaBeam Robotic System for Aquablation therapy furthers the growing trend of robotic technology being implemented in the Northeast Georgia Health System.
This follows a recent advancement seen at NGMC Gainesville, where a new open-heart surgery robot was showcased earlier this year.
